ArticleAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2025

Levosimendan in Patients with Cardiogenic Shock Refractory to Dobutamine Weaning.

Michel Zeitouni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.